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The University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, 3065, AustraliaOne of the mysteries in understanding the pathogenesis of diabetes
is how glucagon-producing alpha cells in the pancreas remain relatively
protected from the toxic environment created by metabolic stress,
while insulin-producing beta cells are not protected and die by apopto-
sis. Metabolic stress refers to conditions of hyperglycemia, or chronical-
ly high levels of plasma glucose, and hyperlipidemia that includes
increased levels of saturated fatty acids of which palmitate is the most
abundant in human plasma. It is believed to be an important cause of
beta cell apoptosis in type 2 diabetes. Marroqui and co-workers have
made inroads into discovering how alpha cells survive metabolic stress
by showing they express higher amounts of survival factors than beta
cells (Marroqui et al., 2015).
In vitro, high concentrations of palmitate, glucose, or both combined
cause beta cell endoplasmic reticulum (ER) stress and apoptosis. Beta
cell ER stress is a known feature of type 2 diabetes in humans and ani-
mal models (Laybutt et al., 2007). Cells respond to ER stress by activat-
ing the unfolded protein response (UPR) signaling pathway. If the ER
stress is mild, UPR signaling results in reduced overall cellular protein
synthesis and increased transcription of ER chaperones to relieve the
ER stress. However, in severe or prolonged ER stress conditions, pro-
apoptotic factors, including CHOP, become activated resulting in cell
death.
The evidence for a role for beta cell ER stress in type 2 diabetes
comes from electron microscopy of ER appearance, as well as protein
and mRNA expression studies in pancreas sections and islets of organ
donors with type 2 diabetes (Butler et al., 2003; Laybutt et al., 2007).
Using electron microscopy, Marroqui and co-workers observed an in-
crease in the volume density of the ER in both alpha and beta cells in
pancreases from type 2 diabetic subjects, a hallmark of the UPR
(Marroqui et al., 2015). The authors also used electron microscopy to
conﬁrm previous reports using TUNEL staining to show an increase in
the number of apoptotic beta cells, but not alpha cells, in pancreases
of type 2 diabetic organ donors compared with those from non-
diabetic donors (Butler et al., 2003; Rahier et al., 2008). This suggested
that while both cell types respond to the metabolic stress conditions
of type 2 diabetes, only the beta cells succumb to apoptotic ER stress.DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.03.012.
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microscopic analysis. Others have suggested that sick beta cells de-
differentiate and degranulate in type 2 diabetes and this could be a
major mechanism of beta cell failure. The authors of the current study
did not comment on whether they saw any apoptotic insulin-negative
beta cells. This is an important question because it is not clear if the
sick beta cells prolong their survival by de-differentiation, or if this is a
step preceding apoptosis.
The authors then went on to study the mechanism of protection of
alpha cells from ER stress-induced apoptosis. The Bcl-2-regulated path-
way of apoptosis is activated by cellular stresses. It is controlled by the
balance between pro-survival and pro-apoptotic members of the Bcl-2
family. The pro-survival proteins include Bcl-2, Bcl-xL, Bcl-w, Mcl-1
and A1. Cellular stress down-regulates these survival factors, allowing
translocation of the multi-domain proteins BAX and BAK to the outer
mitochondrial membrane where they facilitate apoptosis. The pro-
apoptotic BH3-only proteins inhibit the pro-survival members of the
family and are required for initiation of apoptosis signaling. Islets isolat-
ed from organ donors with type 2 diabetes had elevated mRNA expres-
sion of the pro-apoptotic BH3-onlymolecules BIM (BCL2L11) and PUMA
(BBC3) (Wali et al., 2014), highlighting that their activation is cell type
and stimulus-speciﬁc.
Marroqui and co-workers observed higher amounts of Bcl-xL
(Bcl2l1) in alpha cells than in beta cells (Marroqui et al., 2015). Silencing
of Bcl-xL with siRNAmade alpha cells susceptible to palmitate-induced
apoptosis, to the degree observed in beta cells. Silencing another pro-
survival protein, Bcl-2, did not alter the sensitivity of alpha cells to
palmitate-induced apoptosis. It would be interesting to know whether
Mcl-1, another pro-survival protein that is expressed at high levels in is-
lets, also plays a role in alpha cell survival.
The authors conclude that alpha cells are equipped to adapt to and
survivemetabolic stress by expressing higher expression of survival fac-
tors. So why can't beta cells similarly adapt to this stress? Preservation
of beta cell mass in diabetes is something all beta cell biologists would
like to achieve. The mechanisms of loss of beta cell mass is different in
type 1 and type 2 diabetes, but the metabolic outcome is the same,
and beta cell ER stress is a feature of both diseases. Could we make
beta cells more like alpha cells so they are better able to withstand ER
stress-induced apoptosis? Overexpression of pro-survival Bcl-2 family
proteins in beta cells using the insulin promoter in transgenic mice
(e.g. RIP-Bcl2 or RIP-Bcl-xL) protects them from apoptosis induced by
high glucose concentrations or ER stress in vitro (McKenzie et al.,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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secretion and glucose tolerance, indicating that their overexpression
may not be useful for beta cells in conditions of metabolic stress
(Luciani et al., 2013; Zhou et al., 2000).
Alpha cells are also preserved in type 1 diabetes. This is at least in
part due to the speciﬁcity of the immune response to beta cell antigens
such as proinsulin. However, the islets are inﬁltrated by immune cells
that secrete a range of cytotoxic proteins that would presumably affect
alpha cells in a bystandermanner. The current study therefore raises the
possibility that alpha cells may also survive better in an inﬂammatory
environment such as in type 1 diabetes. Indeed in a recent proteomic
study of alpha and beta cell lines, a major difference was observed in
the defense of alpha cells and beta cells against reactive oxygen species
due to differences in expression of superoxide dismutase 2, a major
scavenging enzyme (Gorasia et al., 2015).
It is therefore likely that alpha cells are equippedwithmultiplemech-
anisms thatmaintain their survival in diabetic conditions. Alpha cells have
recently been touted as having a guardian-type role in the islet to main-
tain the body's capacity to produce insulin (Habener and Stanojevic,
2013). There is an emerging role for alpha cells in transdifferentiation
into beta cells, in addition to production of GLP-1, a factor that stimulates
insulin secretion as well as beta cell survival. It therefore makes sense for
these cells to be able to survivemetabolic stress so they can restore insulin
secretory function if necessary. It would be interesting to see whether
alpha cells that have transdifferentiated into beta cells maintain their im-
proved capacity for survival.
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